Wordt geladen...
Statins: Can we advocate them for primary prevention of heart disease?
The discovery of cholesterol-lowering agents, namely HMG-CoA reductase inhibitors or statins, ushered in a series of large cholesterol reduction trials. The first of these studies was the Scandinavian Simvastatin Survival Study (4S) in which hypercholesterolemic men with CHD who were treated with si...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4213925/ https://ncbi.nlm.nih.gov/pubmed/25378782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2013.05.008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|